Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in Greece.

@article{Mylonas2014CostMinimizationAO,
  title={Cost-Minimization Analysis of Trastuzumab Intravenous Versus Trastuzumab Subcutaneous for the Treatment of Patients With HER2+ Early Breast Cancer And Metastatic Breast Cancer in Greece.},
  author={Charalampos C. Mylonas and Georgia C. Kourlaba and George Fountzilas and Anastasios Skroumpelos and Nikolaos Maniadakis},
  journal={Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research},
  year={2014},
  volume={17 7},
  pages={A640-1}
}